Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 6, 1997, Pages 2078-2088

  Koskinen, Petri K ^b   Kallio, Erkki A ^b   Bruggeman, Cathrien A ^b   Lemström, Karl B ^a  

^a Transplantation Laboratory   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ALLOGRAFT; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; INFLAMMATION; MACROPHAGE FUNCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; TRACHEA;

EID: 0030968808     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.6.9196118     Document Type: Article

References (32)

1. Yousem, S. D. A., J. M. Curley, J. Dauber, I. Paradis, H. Rabinowich, A Zeevi, R. Duquesnoy, R. Dowling, M. Zenati, R. Hardesty, and B. P. Griffith. 1990. HLA-class II antigen expression in human heart-lung allografts. Transplantation 49:991-995.
2. Yousem, S. A., L. Ray, I. L. Paradis, J. A. Duaber, and B. P. Griffith. 1990. Potential role of dendritic cells in bronchiolitis obliterans in human heart-lung transplantation. Ann. Thorac. Surg. 49:424-428.
3. Herzt, M. I., C. A. Henke, R. E. Nakhleh, K. R. Harmon, W. A. Marinelli, J. M. K. Fox, S. H. Kubo, S. J. Shumway, R. M. Bolman, III, and P. B. Bitterman. 1992. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 89:10358-10389.
4. Hertz, M. I., J. Jessurun, M. B. King, S. Kay, S. Savik, and J. J. Murray. 1993. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am. J. Pathol. 142:1945-1951.
5. Morris, R. E., X. Huang, R. Shorthouse, H. Reichenspurner, B. Adams, and G. Berry. 1995. Tracheal allograft tranplantation: a model of obliterative airway disease (OAD) and its treatment with new immunosuppressive drugs (abstract). American Society of Transplant Surgeons. 21st Annual Scientific Meeting, Chicago, IL.
6. Koskinen, P. K., E. A. Kallio, R. Krebs, and K. B. Lemström. 1996. A dose-dependent inhibitory effect of cyclosporine A but not of 15-deoxyspergualin or mycophenolate mofetil on obliterative bronchiolitis of rat tracheal allografts. Am. J. Respir. Crit. Care Med. 155: 303-312.
7. Dummer, J. S., L. T. Whire, M. Ho, B. P. Griffith, R. L. Hardesty, and H. T. Bahnson. 1985. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporin. J. Infect. Dis. 152:1182-1191.
8. Grattan, M. T., C. E. Moreno-Cabral, V. A. Starnes, P. E. Oyer, E. B. Stinson, and N. E. Shumway. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J.A.M.A. 261:3561-3566.
9. Everett, J. P., R. E. Hershberger, D. J. Norman, S. Chou, R. M. Ratkovec, A. Cobanoglu, G. Y. Ott, and J. D. Hosenbud. 1992. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J. Heart Lung Transplant. 11: S133-S137.
10. Koskinen, P. K., M. S. Nieminen, L. A. Krogerus, K. B. Lemström, S. P. Mattila, P. J. Häyry, and I. T. Lautenschlager. 1993. Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients. Transplant. Int. 6:341-347.
11. Lemström, K. B., J. H. Bruning, C. A. Bruggeman, I. T. Lautenschlager, and P. J. Häyry. 1993. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J. Clin. Invest 92:549-558.
12. Lemström, K., P. Koskinen, L. Krogerus, M. Daemen, C. Bruggeman, and P. Häyry. 1995. Cytomegalovirus antigen expression, endothelial cell proliferation and intimal thickening in rat cardiac allograft after cytomegalovirus infection. Circulation 92:2594-2604.
13. Keenan, R. J., M. E. Lega, J. S. Dummer, I. L. Paradis, J. H. Dauber, H. Rabinowich, S. A. Yousem, R. L. Hardesty, B. P. Griffith, and R. J. Duquesnoy. 1991. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 51:433-438.
14. Lemström, K., E. Kallio, R. Krebs, C. Bruggeman, P. Häyry, and P. Koskinen. 1996. Cytomegalovirus infection accelerates obliterative bronchiolitis of rat tracheal allografts. Transplant. Int. 9(Suppl. 1):30/1-2.
15. Mayer, E., P. F. Cardoso, J. D. Puskas, K. De-Campos, T. Oka, I. Dardick, and G. A. Patterson. 1992. The effect of basic fibroblast growth factor and omentopexy on revascularization and epithelial regeneration of heterotopic rat tracheal isografts. J. Thorac. Cardiovasc. Surg. 104:180-188.
16. Koskinen, P., K. Lemström, and P. Häyry. 1995. How cyclosporine modifies histologic and molecular events in the vascular wall during chronic rejection of rat heart allografts. Am. J. Pathol. 146:980.
17. Bruggeman, C. A., H. Meijer, P. H. J. Dormans, W. M. H. Debie, G. E. L. M. Grauls, and C. P. van Boven. 1982. Isolation of cytomegalovirus-like agent from wild rats. Arch. Virol. 73:231-241.
18. Meijer, H., P. H. Dormans, J. L. Geelen, and C. P. van Boven. 1984. Rat cytomegalovirus: studies on the viral genome and the proteins of virions and nucleocapsids. J. Gen. Virol. 65:681-695.
19. Wentworth, B., and L. French. 1970. Plaque assay of CMV stains of human origin. Proc. Soc. Exp. Biol. Med. 135:253-258.
20. Bruning, J. H., W. M. H. Debie, G. Rauls, G. Majoor, and C. P. A. van Boven. 1987. The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch. Virol. 94:55-70.
21. Magaud, J.-P., I. Sargent, P. J. Clarke, M. French, R. Rimokh, and D. Y. Mason. 1989. Double immunocytochemical labeling of cell and tissue samples with monoclonal anto-bromodeoxyuridine. J. Histochem. Cytochem. 37:1517-1527.
22. Lemström, K. B., J. H. Bruning, C. A. Bruggeman, I. T. Lautenschlager, and P. J. Häyry. 1994. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Am. J. Pathol. 144:1334-1347.
23. Uyama, T., J. B. Winter, G. Groen, C. R. H. Wildevuur, Y. Monden, and J. Prop. 1992. Late airway changes caused by chronic rejection in rat lung allografts. Transplantation 54:809-812.
24. Häyry, P., H. Isoniemi, S. Yilmaz, A. Mennander, K. Lemström, A. Räisänen-Sokolowski, P. Koskinen, J. Ustinov, I. Lautenschlager, E. Taskinen, L. Krogerus, P. Aho, and T. Paavonen. 1993. Chronic allograft rejection. Immunol. Rev. 134:33-81.
25. Koskinen, P., K. Lemström, C. Bruggeman, I. Lautenschlager, and P. Häyry. 1994. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall: a possible linkage with enhanced allograft arteriosclerosis. Am. J. Pathol. 144:41-50.
26. Ross, R., E. W. Raines, and D. F. Bowen-Pope. 1986. The biology of platelet-derived growth factor. Cell 46:155-169.
27. Mornex, J.-F., Y. Martinet, K. Yamauchi, P. B. Bitterman, G. R. Grotendorst, A. Chytil-Weir, G. R. Martin, and R. G. Crystal. 1985. Spontaneous expression of thec-sis gene and release of a platelet-derived growth factorlike molecule by human alveolar macrophages. J. Clin. Invest. 78:61-66.
28. Martinet, Y., W. N. Rom, G. R. Grotendorst, G. R. Martin, and R. G. Crystal. 1987. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 317:202-209.
29. Al-Dossari, G. A., J. Jessurun, M. Bolman, III, V. R. Kshettry, M. B. King, J. J. Murray, and M. I. Hertz. 1994. Pathogenesis of obliterative bronchiolitis: possible role of platelet-derived growth factor and basic fibroblast growth factor. Transplantation 59:143-145.
30. Zhao, X.-M., T.-K. Yeoh, W. H. Frist, D. L. Porterfield, and G. G. Miller. 1994. Induction of acidic fibroblast growth factor and full-length platelet-derived growth factor expression in human cardiac allografts. Analysis by PCR, in situ hybridization, and immunohistochemistry. Circulation 90:677-685.
31. Lemström, K., and P. Koskinen. 1997. Platelet-derived growth factor ligand and protein expression during acute and chronic rejection of rat cardiac allografts. Circulation (In press)
32. Lemström, K. B., P. T. Aho, C. A. Bruggeman, and P. J. Häyry. 1994. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-β1 in rat aortic allografts. Arterioscler. Thromb. 14:2043-2052.